Le SIDA au Ghana (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Controversial Ebola vaccine trials in Ghana: a thematic analysis of critiques and rebuttals in digital news

Identifieur interne : 000090 ( Main/Exploration ); précédent : 000089; suivant : 000091

Controversial Ebola vaccine trials in Ghana: a thematic analysis of critiques and rebuttals in digital news

Auteurs : Per Egil Kummervold [Norvège] ; William S. Schulz [Royaume-Uni] ; Elizabeth Smout [Royaume-Uni] ; Luis Fernandez-Luque [Norvège, Qatar] ; Heidi J. Larson [Royaume-Uni]

Source :

RBID : PMC:5547580

Abstract

Background

Communication is of paramount importance in responding to health crises. We studied the media messages put forth by different stakeholders in two Ebola vaccine trials that became controversial in Ghana. These interactions between health authorities, political actors, and public citizens can offer key lessons for future research. Through an analysis of online media, we analyse stakeholder concerns and incentives, and the phases of the dispute, to understand how the dispute evolved to the point of the trials being suspended, and analyse what steps might have been taken to avert this outcome.

Methods

A web-based system was developed to download and analyse news reports relevant to Ebola vaccine trials. This included monitoring major online newspapers in each country with planned clinical trials, including Ghana. All news articles were downloaded, selecting out those containing variants of the words “Ebola,” and “vaccine,” which were analysed thematically by a team of three coders. Two types of themes were defined: critiques of the trials and rebuttals in favour of the trials. After reconciling differences between coders’ results, the data were visualised and reviewed to describe and interpret the debate.

Results

A total of 27,460 articles, published between 1 May and 30 July 2015, were collected from nine different newspapers in Ghana, of which 139 articles contained the keywords and met the inclusion criteria. The final codebook included 27 themes, comprising 16 critiques and 11 rebuttals. After coding and reconciliation, the main critiques (and their associated rebuttals) were selected for in-depth analysis, including statements about the trials being secret (mentioned in 21% of articles), claims that the vaccine trials would cause an Ebola outbreak in Ghana (33%), and the alleged impropriety of the incentives offered to participants (35%).

Discussion

Perceptions that the trials were “secret” arose from a combination of premature news reporting and the fact that the trials were prohibited from conducting any publicity before being approved at the time that the story came out, which created an impression of secrecy. Fears about Ebola being spread in Ghana appeared in two forms, the first alleging that scientists would intentionally infect Ghanaians with Ebola in order to test the vaccine, and the second suggesting that the vaccine might give trial participants Ebola as a side-effect – over the course of the debate, the latter became the more prominent of the two variants. The incentives were sometimes criticised for being coercively large, but were much more often criticised for being too small, which may have been related to a misperception that the incentives were meant as compensation for the trials’ risks, which were themselves exaggerated.

Conclusion

The rumours captured through this research indicate the variety of strong emotions drawn out by the trials, highlighting the importance of understanding the emotional and social context of such research. The uncertainty, fear, and distrust associated with the trials draw from the contemporary context of the Ebola outbreak, as well as longstanding historical issues in Ghana. By analysing the debate from its inception, we can see how the controversy unfolded, and identify points of concern that can inform health communication, suggesting that this tool may be valuable in future epidemics and crises.

Electronic supplementary material

The online version of this article (doi:10.1186/s12889-017-4618-8) contains supplementary material, which is available to authorized users.


Url:
DOI: 10.1186/s12889-017-4618-8
PubMed: 28784109
PubMed Central: 5547580


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Controversial Ebola vaccine trials in Ghana: a thematic analysis of critiques and rebuttals in digital news</title>
<author>
<name sortKey="Kummervold, Per Egil" sort="Kummervold, Per Egil" uniqKey="Kummervold P" first="Per Egil" last="Kummervold">Per Egil Kummervold</name>
<affiliation wicri:level="1">
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 0611 6506</institution-id>
<institution-id institution-id-type="GRID">grid.425890.2</institution-id>
<institution></institution>
<institution>Norut Northern Research Institute,</institution>
</institution-wrap>
P.O. Box 6434, Tromso Science Park, N-9294 Tromso, Norway</nlm:aff>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>P.O. Box 6434, Tromso Science Park, N-9294 Tromso</wicri:regionArea>
<wicri:noRegion>N-9294 Tromso</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Schulz, William S" sort="Schulz, William S" uniqKey="Schulz W" first="William S." last="Schulz">William S. Schulz</name>
<affiliation wicri:level="1">
<nlm:aff id="Aff2">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 0425 469X</institution-id>
<institution-id institution-id-type="GRID">grid.8991.9</institution-id>
<institution></institution>
<institution>London School of Hygiene & Tropical Medicine,</institution>
</institution-wrap>
London, UK</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>London</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Smout, Elizabeth" sort="Smout, Elizabeth" uniqKey="Smout E" first="Elizabeth" last="Smout">Elizabeth Smout</name>
<affiliation wicri:level="1">
<nlm:aff id="Aff2">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 0425 469X</institution-id>
<institution-id institution-id-type="GRID">grid.8991.9</institution-id>
<institution></institution>
<institution>London School of Hygiene & Tropical Medicine,</institution>
</institution-wrap>
London, UK</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>London</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Fernandez Luque, Luis" sort="Fernandez Luque, Luis" uniqKey="Fernandez Luque L" first="Luis" last="Fernandez-Luque">Luis Fernandez-Luque</name>
<affiliation wicri:level="1">
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 0611 6506</institution-id>
<institution-id institution-id-type="GRID">grid.425890.2</institution-id>
<institution></institution>
<institution>Norut Northern Research Institute,</institution>
</institution-wrap>
P.O. Box 6434, Tromso Science Park, N-9294 Tromso, Norway</nlm:aff>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>P.O. Box 6434, Tromso Science Park, N-9294 Tromso</wicri:regionArea>
<wicri:noRegion>N-9294 Tromso</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="Aff3">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 1789 3191</institution-id>
<institution-id institution-id-type="GRID">grid.452146.0</institution-id>
<institution>Qatar Computing Research Institute,</institution>
<institution>Hamad Bin Khalifa University,</institution>
</institution-wrap>
Doha, Qatar</nlm:aff>
<country xml:lang="fr">Qatar</country>
<wicri:regionArea>Doha</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Larson, Heidi J" sort="Larson, Heidi J" uniqKey="Larson H" first="Heidi J." last="Larson">Heidi J. Larson</name>
<affiliation wicri:level="1">
<nlm:aff id="Aff2">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 0425 469X</institution-id>
<institution-id institution-id-type="GRID">grid.8991.9</institution-id>
<institution></institution>
<institution>London School of Hygiene & Tropical Medicine,</institution>
</institution-wrap>
London, UK</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>London</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">28784109</idno>
<idno type="pmc">5547580</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547580</idno>
<idno type="RBID">PMC:5547580</idno>
<idno type="doi">10.1186/s12889-017-4618-8</idno>
<date when="2017">2017</date>
<idno type="wicri:Area/Pmc/Corpus">000135</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000135</idno>
<idno type="wicri:Area/Pmc/Curation">000134</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000134</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000037</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000037</idno>
<idno type="wicri:Area/Ncbi/Merge">000B84</idno>
<idno type="wicri:Area/Ncbi/Curation">000B84</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000B84</idno>
<idno type="wicri:Area/Main/Merge">000090</idno>
<idno type="wicri:Area/Main/Curation">000090</idno>
<idno type="wicri:Area/Main/Exploration">000090</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Controversial Ebola vaccine trials in Ghana: a thematic analysis of critiques and rebuttals in digital news</title>
<author>
<name sortKey="Kummervold, Per Egil" sort="Kummervold, Per Egil" uniqKey="Kummervold P" first="Per Egil" last="Kummervold">Per Egil Kummervold</name>
<affiliation wicri:level="1">
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 0611 6506</institution-id>
<institution-id institution-id-type="GRID">grid.425890.2</institution-id>
<institution></institution>
<institution>Norut Northern Research Institute,</institution>
</institution-wrap>
P.O. Box 6434, Tromso Science Park, N-9294 Tromso, Norway</nlm:aff>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>P.O. Box 6434, Tromso Science Park, N-9294 Tromso</wicri:regionArea>
<wicri:noRegion>N-9294 Tromso</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Schulz, William S" sort="Schulz, William S" uniqKey="Schulz W" first="William S." last="Schulz">William S. Schulz</name>
<affiliation wicri:level="1">
<nlm:aff id="Aff2">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 0425 469X</institution-id>
<institution-id institution-id-type="GRID">grid.8991.9</institution-id>
<institution></institution>
<institution>London School of Hygiene & Tropical Medicine,</institution>
</institution-wrap>
London, UK</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>London</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Smout, Elizabeth" sort="Smout, Elizabeth" uniqKey="Smout E" first="Elizabeth" last="Smout">Elizabeth Smout</name>
<affiliation wicri:level="1">
<nlm:aff id="Aff2">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 0425 469X</institution-id>
<institution-id institution-id-type="GRID">grid.8991.9</institution-id>
<institution></institution>
<institution>London School of Hygiene & Tropical Medicine,</institution>
</institution-wrap>
London, UK</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>London</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Fernandez Luque, Luis" sort="Fernandez Luque, Luis" uniqKey="Fernandez Luque L" first="Luis" last="Fernandez-Luque">Luis Fernandez-Luque</name>
<affiliation wicri:level="1">
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 0611 6506</institution-id>
<institution-id institution-id-type="GRID">grid.425890.2</institution-id>
<institution></institution>
<institution>Norut Northern Research Institute,</institution>
</institution-wrap>
P.O. Box 6434, Tromso Science Park, N-9294 Tromso, Norway</nlm:aff>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>P.O. Box 6434, Tromso Science Park, N-9294 Tromso</wicri:regionArea>
<wicri:noRegion>N-9294 Tromso</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="Aff3">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 1789 3191</institution-id>
<institution-id institution-id-type="GRID">grid.452146.0</institution-id>
<institution>Qatar Computing Research Institute,</institution>
<institution>Hamad Bin Khalifa University,</institution>
</institution-wrap>
Doha, Qatar</nlm:aff>
<country xml:lang="fr">Qatar</country>
<wicri:regionArea>Doha</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Larson, Heidi J" sort="Larson, Heidi J" uniqKey="Larson H" first="Heidi J." last="Larson">Heidi J. Larson</name>
<affiliation wicri:level="1">
<nlm:aff id="Aff2">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 0425 469X</institution-id>
<institution-id institution-id-type="GRID">grid.8991.9</institution-id>
<institution></institution>
<institution>London School of Hygiene & Tropical Medicine,</institution>
</institution-wrap>
London, UK</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>London</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">BMC Public Health</title>
<idno type="eISSN">1471-2458</idno>
<imprint>
<date when="2017">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<sec>
<title>Background</title>
<p id="Par1">Communication is of paramount importance in responding to health crises. We studied the media messages put forth by different stakeholders in two Ebola vaccine trials that became controversial in Ghana. These interactions between health authorities, political actors, and public citizens can offer key lessons for future research. Through an analysis of online media, we analyse stakeholder concerns and incentives, and the phases of the dispute, to understand how the dispute evolved to the point of the trials being suspended, and analyse what steps might have been taken to avert this outcome.</p>
</sec>
<sec>
<title>Methods</title>
<p id="Par2">A web-based system was developed to download and analyse news reports relevant to Ebola vaccine trials. This included monitoring major online newspapers in each country with planned clinical trials, including Ghana. All news articles were downloaded, selecting out those containing variants of the words “Ebola,” and “vaccine,” which were analysed thematically by a team of three coders. Two types of themes were defined: critiques of the trials and rebuttals in favour of the trials. After reconciling differences between coders’ results, the data were visualised and reviewed to describe and interpret the debate.</p>
</sec>
<sec>
<title>Results</title>
<p id="Par3">A total of 27,460 articles, published between 1 May and 30 July 2015, were collected from nine different newspapers in Ghana, of which 139 articles contained the keywords and met the inclusion criteria. The final codebook included 27 themes, comprising 16 critiques and 11 rebuttals. After coding and reconciliation, the main critiques (and their associated rebuttals) were selected for in-depth analysis, including statements about the trials being secret (mentioned in 21% of articles), claims that the vaccine trials would cause an Ebola outbreak in Ghana (33%), and the alleged impropriety of the incentives offered to participants (35%).</p>
</sec>
<sec>
<title>Discussion</title>
<p id="Par4">Perceptions that the trials were “secret” arose from a combination of premature news reporting and the fact that the trials were prohibited from conducting any publicity before being approved at the time that the story came out, which created an impression of secrecy. Fears about Ebola being spread in Ghana appeared in two forms, the first alleging that scientists would intentionally infect Ghanaians with Ebola in order to test the vaccine, and the second suggesting that the vaccine might give trial participants Ebola as a side-effect – over the course of the debate, the latter became the more prominent of the two variants. The incentives were sometimes criticised for being coercively large, but were much more often criticised for being too small, which may have been related to a misperception that the incentives were meant as compensation for the trials’ risks, which were themselves exaggerated.</p>
</sec>
<sec>
<title>Conclusion</title>
<p id="Par5">The rumours captured through this research indicate the variety of strong emotions drawn out by the trials, highlighting the importance of understanding the emotional and social context of such research. The uncertainty, fear, and distrust associated with the trials draw from the contemporary context of the Ebola outbreak, as well as longstanding historical issues in Ghana. By analysing the debate from its inception, we can see how the controversy unfolded, and identify points of concern that can inform health communication, suggesting that this tool may be valuable in future epidemics and crises.</p>
</sec>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (doi:10.1186/s12889-017-4618-8) contains supplementary material, which is available to authorized users.</p>
</sec>
</div>
</front>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct>
<analytic>
<author>
<name sortKey="Oyeyemi, So" uniqKey="Oyeyemi S">SO Oyeyemi</name>
</author>
<author>
<name sortKey="Gabarron, E" uniqKey="Gabarron E">E Gabarron</name>
</author>
<author>
<name sortKey="Wynn, R" uniqKey="Wynn R">R Wynn</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Stadler, J" uniqKey="Stadler J">J Stadler</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kaler, A" uniqKey="Kaler A">A Kaler</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kingori, P" uniqKey="Kingori P">P Kingori</name>
</author>
<author>
<name sortKey="Muchimba, M" uniqKey="Muchimba M">M Muchimba</name>
</author>
<author>
<name sortKey="Sikateyo, B" uniqKey="Sikateyo B">B Sikateyo</name>
</author>
<author>
<name sortKey="Amadi, B" uniqKey="Amadi B">B Amadi</name>
</author>
<author>
<name sortKey="Kelly, P" uniqKey="Kelly P">P Kelly</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Okonta, P" uniqKey="Okonta P">P Okonta</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Donaldson, L" uniqKey="Donaldson L">L Donaldson</name>
</author>
<author>
<name sortKey="Mogedal, S" uniqKey="Mogedal S">S Mogedal</name>
</author>
<author>
<name sortKey="El Sayed, N" uniqKey="El Sayed N">N El Sayed</name>
</author>
<author>
<name sortKey="Nduati, R" uniqKey="Nduati R">R Nduati</name>
</author>
<author>
<name sortKey="Goldstein, S" uniqKey="Goldstein S">S Goldstein</name>
</author>
<author>
<name sortKey="Singhal, A" uniqKey="Singhal A">A Singhal</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Braun, C" uniqKey="Braun C">C Braun</name>
</author>
<author>
<name sortKey="Clarke, V" uniqKey="Clarke V">V Clarke</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Landis, Jr" uniqKey="Landis J">JR Landis</name>
</author>
<author>
<name sortKey="Koch, Gg" uniqKey="Koch G">GG Koch</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<affiliations>
<list>
<country>
<li>Norvège</li>
<li>Qatar</li>
<li>Royaume-Uni</li>
</country>
</list>
<tree>
<country name="Norvège">
<noRegion>
<name sortKey="Kummervold, Per Egil" sort="Kummervold, Per Egil" uniqKey="Kummervold P" first="Per Egil" last="Kummervold">Per Egil Kummervold</name>
</noRegion>
<name sortKey="Fernandez Luque, Luis" sort="Fernandez Luque, Luis" uniqKey="Fernandez Luque L" first="Luis" last="Fernandez-Luque">Luis Fernandez-Luque</name>
</country>
<country name="Royaume-Uni">
<noRegion>
<name sortKey="Schulz, William S" sort="Schulz, William S" uniqKey="Schulz W" first="William S." last="Schulz">William S. Schulz</name>
</noRegion>
<name sortKey="Larson, Heidi J" sort="Larson, Heidi J" uniqKey="Larson H" first="Heidi J." last="Larson">Heidi J. Larson</name>
<name sortKey="Smout, Elizabeth" sort="Smout, Elizabeth" uniqKey="Smout E" first="Elizabeth" last="Smout">Elizabeth Smout</name>
</country>
<country name="Qatar">
<noRegion>
<name sortKey="Fernandez Luque, Luis" sort="Fernandez Luque, Luis" uniqKey="Fernandez Luque L" first="Luis" last="Fernandez-Luque">Luis Fernandez-Luque</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000090 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000090 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaGhanaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     PMC:5547580
   |texte=   Controversial Ebola vaccine trials in Ghana: a thematic analysis of critiques and rebuttals in digital news
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:28784109" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a SidaGhanaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Tue Nov 7 18:07:38 2017. Site generation: Tue Mar 5 15:01:57 2024